One Life Sciences' Capability Day

Tuesday, October 24, 2019

SPEAKERS
ABSTRACTS

Agenda

9:00 AM–3:30 PM GE Healthcare Life Sciences Product Showcase & Networking

9:30 AM–10:00 AM Work From Anywhere With UNICORN™ Add Flexibility to Protein Purification Workflows

10:30 AM–11:00 AM Introducing MabSelect™ PrismA

11:15 AM–12:15 PM Single-Use Solutions for Upstream bioprocessing

12:30 PM–1:30 PM Lunch is served

2:00 PM–2:45 PM To Affinity and Beyond

Event details

Date: Tuesday, October 24, 2019
Time: 9:00 AM-3:30 PM
Location: NRC, 6100 Royalmount Ave, Montreal, QC H4P 2R2, Canada

Presenters:
Eric Brassard: Sales Specialist Protein Sciences
Matt Bailey: Technical Sales Specialist, Chromatography
Larry BEll: Bioprocess RFB/Single-Use Technology Sales Specialist
Paul Belcher: Product Strategy Manager, Biacore

Abstracts

Eric Brassard
GE Healthcare Sales Specialist Protein Sciences
Working From Anywhere With UNICORN™ Add Flexibility to Protein Purification Workflows
In this presentation, we will discuss working remotely using UNICORN™. We will examine the required steps to implement this capability thus increasing productivity and flexibility in your research and process development labs.
 
 
Matt Bailey

GE Healthcare Technical Sales Specialist, Chromatography
Introducing MabSelect™ PrismA
Monoclonal antibodies (MAbs) have become the dominant category of biotherapeutics. With high demands on productivity and cost-efficiency, the bioprocessing industry is still facing many challenges. More recently, trends toward high titer expression and purification media has led to productivity gains. We will review the newest chromatography media with improved binding capacity to resolve bottlenecks in production and exceptional alkaline stability for efficient cleaning and sanitization.
 
 
Larry Bell
GE Healthcare Bioprocess RFB/Single-Use Technology Sales Specialist
Single-Use Solutions for Upstream Bioprocessing
This presentation will provide an overview of manufacturing technologies of modern single-use innovations. We will review how these technologies can further increase speed and ensure product quality in process development, manufacturing and facility operations.
 
 
Paul Belcher
GE Healthcare: Product Strategy Manager, Biacore
To Affinity and Beyond
SPR based biosensors are now firmly established as essential tools during the entire drug discovery process – from early stage R&D through to QC and manufacturing. They can be used for a wide range of applications including optimization of protein constructs, verification of proper and consistent protein folding, identification of optimal assay buffer to screening and detailed characterization studies of both low molecular weight and biotherapeutic compounds. In this seminar we will provide an introduction to Biacore SPR with data driven examples highlighting its uses in a broad selection of application areas.

Speaker biographies

Larry Bell

Larry Bell

Sales Specialist – Single Use Technologies, Filtration, Bioreactors at GE Healthcare

Larry holds a B.S. in Chemical Engineering from Worcester Polytechnic Institute and as M.S. in Chemical Engineering from Northeastern University in Boston. Larry has over 13 years’ experience in bioprocessing as an operator, process engineer, application scientist, and product specialist. Larry first joined GE in 2011 as a single-use and filtration specialist and is a recipient of GE’s commercial excellence award in 2013. Larry lives just outside of Boston, MA with his wife and twin daughters.

Paul Belcher

Paul Belcher

Functional Leader, Biacore at GE Healthcare

Paul received his Ph.D. in organic chemistry from the University of Newcastle upon Tyne in the United Kingdom in 2003. During his postdoctoral training, he worked under George Pettit at Arizona State University working on the first total synthesis of the natural product dolastatin 16, a potential cancer therapeutic. While at Arizona State, Paul established a label-free screening program for screening/characterization of large libraries of compounds to enable the development of synthetic probes to challenging targets. At GE his focus has been on the value of drug-target binding kinetics for investigating structure-activity relationships and drug efficacy. He also works on fragment-based lead discovery, interacting predominately with small molecules screening groups within academia and industry to implement and optimize label-free methods for drug discovery. He is a frequent speaker and has given over 400 lectures at conferences and pharma/biotech industry sites and Universities globally.

Matt Bailey

Matt Bailey

Bioprocess Resin Application Specialist for GE Life Sciences

Matt supports a geography of 13 states in the Midwestern US as well as Canada. He received his BS in chemical engineering from Penn State University and his MS in biological sciences from Drexel University. In addition, Matt draws on seven years of process development experience, having worked in the downstream PD group of a large biopharma company, supporting projects ranging from pre-clinical to commercial manufacturing. Additionally, Matt has spent the past six years as a field applications specialist, working with customers to select and implement technologies, including filtration and chromatography products. Matt has been with GE for just over two years.

Product showcase

Wave-25

ÄKTA ready

RTP Columns

Virtual reality

XDM-10